Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

See Remarks

Chief Development Officer

Chief Commercial Officer

Chief Medical Officer

Chief Financial Officer

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal th...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-29	Premium	sold	Premium	Premium	Premium	President & CEO
2024-04-29	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-15	Premium	sold	Premium	Premium	Premium	President & CEO
2024-04-01	Premium	sold	Premium	Premium	Premium	President & CEO
2024-03-25	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-20	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-15	Premium	gifted	Premium	Premium	Premium	See Remarks
2024-02-26	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	President & CEO
2024-02-20	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2024-02-08	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2024-01-16	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-01-16	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks

ARDX - Ardelyx Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ARDX